IndraLab

Statements


| 1

reach
"Similarly, in the angiogenic pathway, celecoxib treatment caused downregulation of IL-6 receptor, the ADAM8 (a disintegrin and metalloproteinase domain 8) gene, CD44 and integrin-beta binding proteins, and upregulation of neuropilin 2 (a VEGF receptor)."